Kemar Brown

897 total citations
16 papers, 427 citations indexed

About

Kemar Brown is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Kemar Brown has authored 16 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Kemar Brown's work include Congenital heart defects research (6 papers), Pluripotent Stem Cells Research (4 papers) and Cardiac Fibrosis and Remodeling (3 papers). Kemar Brown is often cited by papers focused on Congenital heart defects research (6 papers), Pluripotent Stem Cells Research (4 papers) and Cardiac Fibrosis and Remodeling (3 papers). Kemar Brown collaborates with scholars based in United States, United Kingdom and Australia. Kemar Brown's co-authors include Ramachandran S. Vasan, Matthew Nayor, Ann Foley, Michael Xavier Doss, Anna‐Katerina Hadjantonakis, Jérôme Artus, Mohammad Tofael Kabir Sharkar, Manuel Mayr, Ajay M. Shah and Ann Kurian and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Kemar Brown

14 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kemar Brown United States 8 312 113 82 48 40 16 427
А. В. Киселева Russia 11 110 0.4× 103 0.9× 50 0.6× 23 0.5× 69 1.7× 75 332
Zongwei Lin China 10 204 0.7× 69 0.6× 24 0.3× 90 1.9× 39 1.0× 19 388
Luocheng Li China 10 154 0.5× 70 0.6× 45 0.5× 77 1.6× 16 0.4× 20 345
Justin Chin-Bong Choi United States 7 209 0.7× 50 0.4× 59 0.7× 28 0.6× 22 0.6× 15 358
Juan Xu China 13 255 0.8× 256 2.3× 40 0.5× 153 3.2× 9 0.2× 31 516
Justin Yu United States 10 110 0.4× 33 0.3× 35 0.4× 28 0.6× 62 1.6× 25 309
Shiwei Yang China 10 151 0.5× 64 0.6× 28 0.3× 33 0.7× 11 0.3× 51 266
Shuyi Han China 10 161 0.5× 26 0.2× 34 0.4× 42 0.9× 19 0.5× 15 358
Anna Kieronska‐Rudek Poland 9 93 0.3× 53 0.5× 27 0.3× 51 1.1× 20 0.5× 17 282
Adán Valladares Mexico 10 156 0.5× 35 0.3× 51 0.6× 27 0.6× 188 4.7× 14 394

Countries citing papers authored by Kemar Brown

Since Specialization
Citations

This map shows the geographic impact of Kemar Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemar Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemar Brown more than expected).

Fields of papers citing papers by Kemar Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemar Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemar Brown. The network helps show where Kemar Brown may publish in the future.

Co-authorship network of co-authors of Kemar Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Kemar Brown. A scholar is included among the top collaborators of Kemar Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemar Brown. Kemar Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mielniczuk, Lisa, Tariq Ahmad, Josip A. Borovac, et al.. (2025). Management of Ischemic Heart Disease in Patients With Heart Failure. JACC Heart Failure. 13(12). 102731–102731.
2.
3.
Brown, Kemar, et al.. (2021). Social determinants of telemedicine utilization in ambulatory cardiovascular patients during the COVID-19 pandemic. European Heart Journal - Digital Health. 2(2). 244–253. 14 indexed citations
4.
Brown, Kemar, et al.. (2021). DETERMINANTS OF TELEMEDICINE UTILIZATION IN AMBULATORY CARDIOVASCULAR CARE DURING THE COVID-19 PANDEMIC. Journal of the American College of Cardiology. 77(18). 3173–3173. 1 indexed citations
5.
Abboud, Andrew, Kemar Brown, David M. Dudzinski, et al.. (2021). Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study. Open Heart. 8(2). e001704–e001704. 4 indexed citations
6.
Nayor, Matthew, Kemar Brown, & Ramachandran S. Vasan. (2021). The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk. Circulation Research. 128(2). 287–303. 84 indexed citations
7.
Magadum, Ajit, Neha Singh, Ann Kurian, et al.. (2020). Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration. Circulation. 141(15). 1249–1265. 201 indexed citations
8.
Hunter, Andrew W., et al.. (2019). TAK1/Map3k7 enhances differentiation of cardiogenic endoderm from mouse embryonic stem cells. Journal of Molecular and Cellular Cardiology. 137. 132–142. 2 indexed citations
9.
Brown, Kemar, et al.. (2017). Overexpression of Map3k7 activates sinoatrial node-like differentiation in mouse ES-derived cardiomyocytes. PLoS ONE. 12(12). e0189818–e0189818. 7 indexed citations
10.
Brown, Kemar, et al.. (2015). Mineralocorticoid Receptor Antagonism in Acute Heart Failure. Current Treatment Options in Cardiovascular Medicine. 17(9). 402–402. 3 indexed citations
11.
Isherwood, Jennifer, et al.. (2013). Label free proteomics: a methodology for identifying protein biomarkers in pancreatic cancer. Annals of The Royal College of Surgeons of England. 95(6). e22–e22. 7 indexed citations
12.
13.
Brown, Kemar, Jérôme Artus, Michael Xavier Doss, et al.. (2010). A Comparative Analysis of Extra-Embryonic Endoderm Cell Lines. PLoS ONE. 5(8). e12016–e12016. 45 indexed citations
14.
Brown, Kemar, et al.. (2010). eXtraembryonic ENdoderm (XEN) Stem Cells Produce Factors that Activate Heart Formation. PLoS ONE. 5(10). e13446–e13446. 29 indexed citations
15.
Maurer, Alan H., J.L. Urbain, Benjamin Krevsky, et al.. (1998). Effects of in vitro versus in vivo red cell labeling on image quality in gastrointestinal bleeding studies.. PubMed. 26(2). 87–90. 6 indexed citations
16.
Barnett, G. Octo, et al.. (1982). COSTAR: A Comprehensive Medical Information System for Ambulatory Care. PubMed Central. 8–18. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by А. В. Киселева Breakdown of academic impact, for papers by Zongwei Lin Breakdown of academic impact, for papers by Luocheng Li Breakdown of academic impact, for papers by Justin Chin-Bong Choi Breakdown of academic impact, for papers by Juan Xu Breakdown of academic impact, for papers by Justin Yu Breakdown of academic impact, for papers by Shiwei Yang Breakdown of academic impact, for papers by Shuyi Han Breakdown of academic impact, for papers by Anna Kieronska‐Rudek Breakdown of academic impact, for papers by Adán Valladares
Rankless by CCL
2026